You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Phentermine resin complex - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for phentermine resin complex and what is the scope of patent protection?

Phentermine resin complex is the generic ingredient in three branded drugs marketed by Ucb Inc, Quantum Pharmics, and Lannett Co Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Summary for phentermine resin complex
Recent Clinical Trials for phentermine resin complex

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins UniversityPhase 4
WW International Inc.Phase 4
KVK-Tech, Inc.Phase 4

See all phentermine resin complex clinical trials

US Patents and Regulatory Information for phentermine resin complex

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc PHENTERMINE RESIN COMPLEX phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 040872-002 Jul 28, 2011 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc IONAMIN phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 011613-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Quantum Pharmics PHENTERMINE RESIN 30 phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 089120-001 Feb 4, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Lannett Co Inc PHENTERMINE RESIN COMPLEX phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 040872-001 Jul 28, 2011 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc IONAMIN phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 011613-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.